Nymox Pharmaceutical
NYMX
#10560
Rank
NZ$32.11 M
Marketcap
Country
NZ$0.35
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Nymox Pharmaceutical (NYMX)

Earnings in 2023 (TTM): -NZ$3.79 Million

According to Nymox Pharmaceutical's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -NZ$11.49 Million, an increase over its 2021 earnings that were of -NZ$21.96 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nymox Pharmaceutical from 1997 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -NZ$3.79 Million-67%
2022 -NZ$11.49 Million-47.71%
2021 -NZ$21.96 Million6.61%
2020 -NZ$20.6 Million-10.91%
2019 -NZ$23.12 Million24.24%
2018 -NZ$18.61 Million-20.03%
2017 -NZ$23.27 Million2.71%
2016 -NZ$22.66 Million-63.86%
2015 -NZ$62.7 Million674.44%
2014 -NZ$8.1 Million-6.11%
2013 -NZ$8.63 Million-35.66%
2012 -NZ$13.41 Million-20.76%
2011 -NZ$16.92 Million38.33%
2010 -NZ$12.23 Million35.59%
2009 -NZ$9.02 Million11.8%
2008 -NZ$8.07 Million-12.94%
2007 -NZ$9.27 Million8.85%
2006 -NZ$8.52 Million36.5%
2005 -NZ$6.24 Million-4.4%
2004 -NZ$6.53 Million-14.58%
2003 -NZ$7.64 Million
2001 -NZ$5.61 Million-20.54%
2000 -NZ$7.05 Million21.72%
1999 -NZ$5.8 Million-25.56%
1998 -NZ$7.78 Million101.3%
1997 -NZ$3.87 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$45.70 B-1,202,274.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$18.63 B-490,197.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$14.31 B-376,638.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$54.76 B-1,440,405.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$2.42 B-63,774.22%๐Ÿ‡บ๐Ÿ‡ธ USA